AllianceBernstein’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
Other funds holding LJPC
TCM
RI
BC
AllianceBernstein's LJPC Position: Q2 2021 in Review
AllianceBernstein sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 82,600 shares — an estimated $350K sold.
AllianceBernstein first reported a position in LJPC in Q4 2015 and held it in 21 quarters. The position peaked at $3.34M in Q1 2018. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.
- AllianceBernstein reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
- AllianceBernstein sold 82,600 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $350K.
- AllianceBernstein first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and held it in 21 quarters.
- AllianceBernstein's La Jolla Pharmaceutical Company position peaked at $3.34M in Q1 2018.
- 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.
Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.